TALSURE

This brand name is authorized in Nigeria.

Active ingredients

The drug TALSURE contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5229	Tablet	TALSURE 500 TABLETS TAB 500 mg 1 X 10	80 RNW-PP-225878 TALSURE 500 TABLETS CEFUROXIME AXETIL TABLETS USP 500MG Each film coated tablet contains: Cefuroxime Axetil USP equivalent to Cefuroxime 500mg Excipients q.s. Colour: Titanium Oxide B4-5229 Drugs Imported Products 1x10 Prescription Only Medicine (POM) 10/13/2021 PRIYA PHARMACEUTICAL NIG LTD, AIRPORT ROAD 2F, KANO KANO 21020502 PRIYAPHARMACEUTICAL@HOTMAIL.COM BRUSSELS LABORATORIES PVT LTD, NO. 33, CHANGODAR INDUSTRIAL ESTATE, SARKEJ- BAVLA ROAD, CHANGODA-382210 DIS AHMEDABAD, GUJARAT,INDIA., India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5229